Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.9% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
0
users have commented on this narrative
31
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
24.3% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.0% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
14
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Somnigroup International
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Growing Global Demand Will Expand Sleep And Wellness Markets
Key Takeaways International expansion, new products, and customization are driving long-term growth opportunities in both revenue and margins for Somnigroup. Integration of Mattress Firm and strategic manufacturing are improving operational efficiency, cost savings, and margin stability despite short-term cost pressures.
View narrative
US$80.89
FV
0.1% overvalued
intrinsic discount
12.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
Updated
narrative
Silence Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
ALPACAR-360 Success And AstraZeneca Collaboration Will Advance siRNA Pipeline
Key Takeaways The company's strategic partnerships and collaborations could reduce financial risk and enhance revenue growth through shared commercialization and milestone payments. Successful study results and orphan drug designation might lead to dominance in niche markets, improving future earnings and net margins.
View narrative
US$37.26
FV
84.3% undervalued
intrinsic discount
30.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
11
users have followed this narrative
Updated
narrative
Kiniksa Pharmaceuticals International
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Broader Biologic Adoption Will Unlock Undervalued Market Potential
Key Takeaways Widening market adoption and evolving treatment guidelines for ARCALYST are driving sustained revenue growth and strengthening the company's competitive stance. Diverse pipeline advances and strong financial discipline support long-term earnings growth, operational leverage, and continued innovation investment.
View narrative
US$46.50
FV
27.6% undervalued
intrinsic discount
23.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
6 days ago
author updated this narrative
Cardlytics
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
US Neobank And Taiwan Office Will Unlock New Markets
Key Takeaways Expansion into new sectors and partnerships with financial institutions and neobanks is expected to diversify the customer base and boost revenue. Enhancements in advertising and strategic investments in technology target increased sales, improved operational efficiency, and better net margins.
View narrative
US$2.10
FV
37.6% undervalued
intrinsic discount
-7.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
Updated
narrative
GoodRx Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Digital Healthcare And Pharmacy Networks Will Unlock Market Potential
Key Takeaways Expanded pharmacy partnerships, digital integration, and technology investment are driving stronger platform engagement, deeper ecosystem influence, and higher earnings resilience. Brand trust and network breadth help offset near-term retail disruptions, supporting revenue stability and sustained margin durability despite industry headwinds.
View narrative
US$5.91
FV
39.8% undervalued
intrinsic discount
6.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
Updated
narrative
Seplat Energy
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Increasing Nigerian Gas Production Will Spur Demand Amid Challenges
Key Takeaways Expansion in gas production and integration of new assets positions Seplat to capture growing demand and increase market share in Nigeria's cleaner energy sector. Operational efficiencies, low leverage, and strong liquidity enable Seplat to pursue acquisitions and maintain sustainable earnings growth.
View narrative
UK£3.28
FV
21.9% undervalued
intrinsic discount
11.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
6 days ago
author updated this narrative
Prestige Consumer Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Pillar5 Acquisition And Ecommerce Momentum Will Foster Enduring Supply Reliability
Key Takeaways Supply chain improvements and strong e-commerce momentum are expected to support revenue growth and operational efficiency, particularly in eye care and international segments. Consistent cash flow and disciplined cost management enable financial flexibility, margin stability, and future EPS growth for shareholders.
View narrative
US$82.80
FV
19.8% undervalued
intrinsic discount
1.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
Claritev
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Digital Transformation And AI Adoption Will Drive Global Healthcare Expansion
Key Takeaways Accelerated AI adoption, cloud migration, and automation initiatives enhance product development, operational efficiency, and margin stability, supporting long-term cash flow and reinvestment potential. Expansion into international and emerging markets, along with strong client renewals and strategic partnerships, underpins sustainable revenue growth and broadens Claritev's market reach.
View narrative
US$49.50
FV
42.2% overvalued
intrinsic discount
3.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
Vontier
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Digital Payment And SaaS Will Transform Fueling Industry
Key Takeaways Expansion of high-margin digital solutions and recurring SaaS services is boosting revenue predictability and margin growth, cementing a strong competitive market position. Operational efficiency initiatives and portfolio optimization are set to further improve profitability and support sustained long-term earnings growth.
View narrative
US$47.65
FV
9.4% undervalued
intrinsic discount
4.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 6 hours ago
author updated this narrative
Value any company in seconds
Popular companies